COWA LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

COWA LLC’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,187	Closed	-$442K	–	143
2021 Q2	$442K	Hold	2,187	–	–	0.28%	65
2021 Q1	$467K	Buy	+2,187	New	+$480K	0.28%	64

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

COWA LLC's VRTX Position: Q3 2021 in Review

COWA LLC sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 2,187 shares — an estimated $442K sold.

COWA LLC first reported a position in VRTX in Q1 2021 and held it in 2 quarters. The position peaked at $467K in Q1 2021. 933 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

COWA LLC reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
COWA LLC sold 2,187 Vertex Pharmaceuticals shares in Q3 2021, an estimated $442K.
COWA LLC first reported a position in Vertex Pharmaceuticals in Q1 2021 and held it in 2 quarters.
COWA LLC's Vertex Pharmaceuticals position peaked at $467K in Q1 2021.
933 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on COWA LLC's 13F filing for Q3 2021, filed 22 Oct 2021.